Home » Health » in the country – prepares to produce a combined vaccine to combat the global virus extracted from 3 types of germs

in the country – prepares to produce a combined vaccine to combat the global virus extracted from 3 types of germs

fight the global virus

extracted from 3 types of germs

Covid-influenza-RSV

Medical Genome Center revealed. Results in a laboratory at the University of Glasgow, England, which studied a hybrid virus. It’s a mix of coronavirus and flu. Symptoms can be more severe than any virus infection. Leading vaccine manufacturers have accelerated the production of a combination vaccine from the coviral influenza virus-RSV by injecting a single dose for young children and the elderly. Preventing Respiratory Diseases From All Viruses D-Day begins Phase One human research in late 2022.

On October 27, reporters reported that Medical Genome Center Faculty of Medicine Ramathibodi Hospital Mahidol University Facebook post claims that monitoring the development of the virus. Worried about hybrid viruses? caused by the fusion of two types of viral particles, the RSV virus and influenza virus together It was found that it was able to evade the immune system of the influenza virus as well.

This is due to a research team from the University of Glasgow. Two types of viruses have been tested in England: RSV (Respiratory Syncytial Virus) and influenza viruses which are both RNA viruses were grown together with lung cells grown in vitro. It appears that instead of both types of viruses competing to infiltrate the cell, there is no chance that another type of virus will follow. For example, in the case of coronavirus 2019 or COVID-19, the particle walls of the RSV and influenza virus were found to be fused with separate genomes. has become a new type of hybrid virus.

This was also stated by the Genome Center From in vitro tests, A hybrid between RSV and influenza virus was found. Access to a wider range of target cells The influenza virus originally infects the upper respiratory tract, such as cells in the nose, throat and trachea, while the RSV virus invades the lower respiratory tract. bronchial and lung cells It is the leading cause of pneumonia in young children and the elderly. This leads to hospitalizations and thousands of deaths every year. But the in vitro hybrid virus is thought to infect the nose, throat, trachea and lungs if it spreads to humans, making a person infected with a hybrid virus more likely to be more severe than RSV or any flu virus. and hybrid viruses can infect neighboring cells. The area also has antibodies to the flu virus. This usually prevents the flu virus from entering the cells, but don’t panic. Because we only found the hybrid virus in the University of Glasgow laboratory. There have been no reports of this type of hybrid virus causing human disease.

Major vaccine companies are also ramping up production of an mRNA combination vaccine against the coronavirus. 2019-Influenza virus-RSV in a single injection given to young children and the elderly to prevent viral respiratory infections. Phase I of the clinical trial will begin in late 2022. Preliminary animal data show that it can induce a highly satisfactory immune response to all three types of viruses simultaneously. Infection with the coronavirus hybrid virus is expected to be prevented. Influenza virus RSV 2019 is also possible. Therefore, hybrid viral outbreaks, if they occur in the future, could be difficult to transmit in children who received the combination vaccine during coronavirus. 2019-flu virus-RSV virus

Assoc. Prof. Dr. Teera Woratanarat, Chulalongkorn University Faculty of Medicine Publishes daily on Facebook about the situation of Covid-19 which so far the world has infected 298,286 more people with 896 more deaths, for a total of 634,066,329 cumulative infections and 6,587. 042 deaths, of which the top 5 Most infected are Japan, France, South Korea, Taiwan and Italy.In the meantime, progress has been reported in monitoring COVID-19. The World Health Organization (WHO) also published the WHO weekly epidemiological update on October 26, identifying the COVID-19 virus. Omikron species still dominate the global epidemic. Up to 99.7% were detected. Currently 390 subspecies of omicron have been sprouted, of which 48 subspecies have been crossed to form recombinant BA strains. 5 are also found in a high percentage of 77.1%, BA.4 5.4%, BA. 2 4.3%.

For XBB subspecies which are very resistant to immunity. It has been found to be distributed in 35 countries around the world. While subspecies BQ.1.x has spread to 65 countries, the important thing is that the resulting subspecies, BA.2, BA.4, and BA.5, mutated into the cortical spines of BQ.1.x. Virus (Spike) in the position of many identical amino acids. Identical mutations of each subspecies that are not direct descendants. Indicates that the virus has evolved in the same direction (convergent evolution) must be carefully monitored. because it can affect the performance of the virus.

The Assoc. Prof. Dr. Teera The current situation of COVID-19 in Thailand There are still continuing infections around them. People should be careful Protect yourself regularly throughout everyday life.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.